ACM
ADAR1 Capital Management Portfolio holdings
AUM
$616M
This Quarter Return
-4.37%
1 Year Return
+26.77%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$520M
AUM Growth
+$520M
(+7.1%)
Cap. Flow
+$56.8M
Cap. Flow
% of AUM
10.93%
Top 10 Holdings %
Top 10 Hldgs %
45.71%
Holding
253
New
46
Increased
68
Reduced
40
Closed
49
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$14.9M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$9.17M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$8.55M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.34M |
| 5 |
RAPT Therapeutics
RAPT
|
$5.85M |
Top Sells
| 1 |
BridgeBio Pharma
BBIO
|
$11.7M |
| 2 |
Ascendis Pharma
ASND
|
$10.9M |
| 3 |
Mineralys Therapeutics
MLYS
|
$9.18M |
| 4 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
$6.59M |
| 5 |
Sanofi
SNY
|
$4.8M |
Sector Composition
| 1 | Healthcare | 80.96% |
| 2 | Financials | 3.59% |
| 3 | Consumer Discretionary | 0.06% |
| 4 | Utilities | 0.02% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arcellx
ACLX
$3.87B
| $916K | 0.17% |
13,962
+10,000
| +252% | +$656K |
|
77
Regeneron Pharmaceuticals
REGN
$61.4B
| $863K | 0.16% |
1,361
| – | – |
|
78
Keen Vision Acquisition Corporation Units
KVACU
| $842K | 0.16% |
75,000
| – | – |
|
79
Agios Pharmaceuticals
AGIO
$2.35B
| $817K | 0.15% |
+27,900
| New | +$817K |
|
|
GRCE
80
Grace Therapeutics, Inc. Common Stock
GRCE
$41.1M
| $783K | 0.15% |
343,512
-430,123
| -56% | -$981K |
|
81
Kezar Life Sciences
KZR
$28.8M
| $719K | 0.13% |
147,404
| – | – |
|
82
Arrowhead Research
ARWR
$3.72B
| $717K | 0.13% |
56,300
+43,400
| +336% | +$553K |
|
83
Structure Therapeutics
GPCR
$1.18B
| $617K | 0.11% |
35,619
+300
| +0.8% | +$5.19K |
|
84
Biogen
BIIB
$20.8B
| $616K | 0.11% |
4,500
+1,455
| +48% | +$199K |
|
|
ITOS
85
DELISTED
iTeos Therapeutics
ITOS
| $604K | 0.11% |
101,096
-30,503
| -23% | -$182K |
|
86
Natera
NTRA
$23.3B
| $601K | 0.11% |
+4,250
| New | +$601K |
|
87
Zymeworks
ZYME
$1.06B
| $596K | 0.11% |
+50,000
| New | +$596K |
|
88
Lexeo Therapeutics
LXEO
$266M
| $591K | 0.11% |
170,448
+943
| +0.6% | +$3.27K |
|
89
Kiora Pharmaceuticals
KPRX
$9.65M
| $586K | 0.11% |
194,665
-5,556
| -3% | -$16.7K |
|
90
Spero Therapeutics
SPRO
$119M
| $577K | 0.11% |
801,277
| – | – |
|
91
Biohaven
BHVN
$1.68B
| $544K | 0.1% |
+22,641
| New | +$544K |
|
92
Protara Therapeutics
TARA
$125M
| $523K | 0.1% |
122,690
| – | – |
|
93
WisdomTree Floating Rate Treasury Fund
USFR
$18.8B
| $503K | 0.09% |
10,000
| – | – |
|
|
ANSC
94
Agriculture & Natural Solutions Acquisition Corp
ANSC
$471M
| $502K | 0.09% |
47,062
-33,300
| -41% | -$355K |
|
95
Eli Lilly
LLY
$659B
| $496K | 0.09% |
600
-750
| -56% | -$619K |
|
96
Madrigal Pharmaceuticals
MDGL
$9.5B
| $494K | 0.09% |
+1,490
| New | +$494K |
|
97
Vaxcyte
PCVX
$4.11B
| $483K | 0.09% |
+12,800
| New | +$483K |
|
98
RenovoRx
RNXT
$41M
| $475K | 0.09% |
479,883
+282,633
| +143% | +$280K |
|
99
Alector
ALEC
$274M
| $468K | 0.09% |
380,330
+12,000
| +3% | +$14.8K |
|
100
Insmed
INSM
$30.6B
| $463K | 0.09% |
6,074
-15,900
| -72% | -$1.21M |
|